Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy

Cancer-related immunosuppression is one of the most challenging aspects of cancer therapy, being one of the principal causes of disease relapse. Most recent immunotherapeutic strategies have been at the forefront of therapies to overcome this problem through targeting T cell-related pathways. Notwit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves, Flávia Castro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2022-08-01
Serie:Materials Today Advances
Soggetti:
Cancer therapy
Cancer theranostics
Immunomodulation
Immune adjuvants
Accesso online:http://www.sciencedirect.com/science/article/pii/S2590049822000480
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi